Sanofi traded at $55.06 this Friday May 27th, decreasing $0.44 or 0.79 percent since the previous trading session. Looking back, over the last four weeks, Sanofi lost 1.33 percent. Over the last 12 months, its price rose by 3.97 percent. Looking ahead, we forecast Sanofi to be priced at 53.17 by the end of this quarter and at 47.89 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
55.06
Daily Change
-0.79%
Yearly
3.97%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 150.01 -0.56 -0.37% 32.52%
Amgen 255.19 2.14 0.84% 7.25%
AstraZeneca 10,474.00 -72.00 -0.68% 30.18%
Astrazeneca 66.70 0 0% 17.24%
Bristol-Myers Squibb 76.14 -1.45 -1.87% 15.86%
Corcept Therapeutics 20.11 0 0% -7.20%
Catalent 105.37 4.40 4.36% 0.52%
Endo International 0.48 0.01 1.38% -91.87%
Genmab 2,138.00 14.00 0.66% -12.12%
Galapagos 52.90 0.48 0.92% -15.76%
GlaxoSmithKline 1,738.00 -15.80 -0.90% 29.30%
Glaxosmithkline 44.08 -0.35 -0.78% 14.51%
Horizon Pharma 94.83 4.24 4.68% 3.46%
Jazz Pharmaceuticals 152.11 -0.35 -0.23% -13.46%
J&J 181.11 1.65 0.92% 7.01%
Lannett 0.52 0.01 2.82% -89.51%
Eli Lilly 323.51 10.05 3.21% 61.97%
H Lundbeck A/S 162.50 0.15 0.09% -17.97%
Merck & Co 93.09 0.79 0.86% 22.66%
Novartis 86.92 -0.90 -1.02% 8.66%
Novartis 90.88 -0.38 -0.42% 2.71%
Phibro Animal Health 19.46 0.46 2.42% -30.97%
Prestige Brands 56.45 0.54 0.97% 12.23%
Pacira 63.04 0.86 1.38% 2.89%
Pfizer 53.89 -0.10 -0.19% 39.14%
Powershares High Yield Orate Bond Portfolio 18.00 0.11 0.61% -7.17%
Perrigo 40.34 0.18 0.45% -12.57%
Drreddys Laboratories 56.16 0.89 1.61% -22.24%
Roche Holding 328.20 -4.80 -1.44% 4.79%
Supernus Pharmaceuticals 28.32 0.87 3.17% -5.13%
Teva Pharmaceutical Industries 8.90 -0.18 -1.98% -14.26%
UCB 81.88 -0.78 -0.94% 8.22%
United States Oil Fund 84.94 0.35 0.41% 87.01%
Canopy Growth Corp 6.15 -0.97 -13.62% -80.45%
Zoetis 171.16 5.26 3.17% -2.01%


Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.